FDA greenlights treatment for pediatric heart condition

CORAL GABLES, Fla. – The Food and Drug Administration has given special designation to a treatment for life-threatening childhood heart disease.

dr. Anthony Rossi, a pediatric cardiologist at Nicklaus Children’s Hospital, said the treatment could complement surgery in babies born with hypoplastic left heart syndrome, in which the left side of the heart doesn’t function.

“This is very exciting, what we’re talking about is a stem cell therapy where stem cells are injected directly into the heart during one of the scheduled surgeries, so it’s not an extra procedure and the idea is that the stem cells will either make new heart muscle cells or the cells make the ones out there work better.” he said.

Rossi said that for babies who have critical illness, hypoplastic left heart syndrome is one of the most common seen in large congenital heart centers and is one hundred percent fatal without treatment.


And a first-of-its-kind study found that probiotics can significantly improve some of the so-called morning sickness and other common problems women face during pregnancy.

Probiotics, found in supplements and foods like yogurt, can support the gastrointestinal tract affected by hormonal changes during pregnancy.

Researchers at the UC Davis School of Medicine found that study participants experienced less pregnancy-related nausea, vomiting and constipation.

Previous studies have shown the benefit of probiotics in preventing liver inflammation.

Further research may look at the use of probiotics to treat nausea and vomiting in cancer patients undergoing chemotherapy.

Copyright 2021 by WPLG Local10.com – All rights reserved.

Comments are closed.